newsfilter
← Latest News
PR Newswire·

Amgen Successfully Completes Acquisition Of Five Prime Therapeutics

Amgen (NASDAQ:AMGN) today announced that it has successfully completed its previously announced tender offer to purchase all outstanding shares of...